Will the COVID-19 pandemic affect HCV disease burden?

Dig Liver Dis. 2020 Sep;52(9):947-949. doi: 10.1016/j.dld.2020.05.040. Epub 2020 May 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / epidemiology*
  • Disease Eradication
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / epidemiology*
  • Hepatitis C, Chronic / prevention & control
  • Humans
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Time-to-Treatment*

Substances

  • Antiviral Agents